See analyst estimates and all valuation multiples for Nutraceuticals & Cosmeceuticals
Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
$24.5B | 1.5x | 6.6x | |
$18.3B | 16.5x | 52.0x | |
$17.3B | 11.2x | 34.2x | |
$9.4B | 3.0x | 7.4x | |
$7.3B | 9.7x | 36.3x | |
$6.5B | 4.2x | 21.3x | |
$3.7B | 1.9x | 12.4x | |
$3.7B | 1.7x | 9.8x | |
$3.6B | n/a | n/a | |
$3.3B | 2.5x | 9.3x | |
$2.7B | 9.6x | 23.7x | |
$2.5B | 8.7x | 17.3x | |
$1.6B | n/a | n/a | |
$1.5B | 6.4x | 25.6x | |
$1.2B | 2.2x | 11.2x | |
$1.2B | 1.1x | 4.1x | |
$1.0B | n/a | n/a | |
$956M | n/a | n/a | |
$944M | 7.0x | 26.4x | |
$923M | 6.1x | 17.9x | |
$889M | 3.6x | 9.3x | |
$847M | n/a | n/a | |
$679M | 1.5x | 7.1x | |
$579M | 4.3x | 15.8x | |
$548M | 2.2x | 9.3x | |
$536M | 1.4x | n/a | |
$476M | 9.8x | 27.7x | |
$203M | 3.0x | n/a | |
$156M | 2.4x | 10.9x | |
$95.0M | n/a | n/a | |
$25.7M | n/a | n/a | |
$21.3M | 0.9x | -78.0x | |
$17.2M | n/a | n/a | |
$13.1M | 6.0x | -1.2x | |
$10.1M | n/a | n/a | |
$3.7M | n/a | n/a | |
$1.8M | n/a | n/a | |
-$4.6M | n/a | n/a | |
-$24.4M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Nutraceuticals & Cosmeceuticals